Iron Infusion in Patients Undergoing Transcatheter Aortic Valve Implantation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 402 participants.
Also called NCT07370688
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 402 participants
- Sponsor
- Registry
-
NCT07370688
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Netherlands
- Registry status
- Recruiting
Technical summary
Registry record NCT07370688. Randomized; no masking; primary purpose treatment. Start 2024-08-12 (actual); primary completion 2028-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Iron Infusion in Patients Undergoing Transcatheter Aortic Valve Implantation
- Acronym
- IRON TAVI
- Condition
- Aortic Valve Stenosis
- Condition
- Iron Deficiency
- Condition
- TAVI(Transcatheter Aortic Valve Implantation)
- Condition
- Cardiovascular Diseases
- Intervention (Drug)
- Intravenous ferric carboxymaltose
- Lead sponsor
- Erasmus Medical Center
Record details
- Record id
cardio:ct-nct07370688- Content hash
f284f669cd275c77e4af3d3d5585a8b4dc73692cb7c4133a34373f9d354a58e3